On the one hand, in the TME, MCs can release angiogenic molecules such as VEGF-A, CXCL-8, FGF-2, VEGF-C, MMP-2, and MMP-9 [198], thus promoting tumor vascularization and invasiveness [204]. The gene discussed is CXCL8; the disease is neoplasm.